Myrbetriq 50 mg/1
mirabegron · TABLET, FILM COATED, EXTENDED RELEASE · Astellas Pharma US, Inc.
No Recall History
Plain English
Myrbetriq is a tablet, film coated, extended release containing mirabegron at 50 mg/1, taken oral. Manufactured by Astellas Pharma US, Inc..
Key Facts
- Brand Name
- Myrbetriq
- Generic Name
- mirabegron
- NDC Code (Product)
0469-2602- Manufacturer
- Astellas Pharma US, Inc.
- Strength
- 50 mg/1
- Dosage Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA202611
- Drug Class
- beta3-Adrenergic Agonist [EPC]
- Marketing Start
- 06/28/2012
Recall History
No Recall HistoryFrequently Asked Questions
What is Myrbetriq used for?
Myrbetriq contains mirabegron. It is a tablet, film coated, extended release taken oral. Consult your doctor for specific uses.
Is Myrbetriq a controlled substance?
Myrbetriq is not classified as a controlled substance by the DEA.
What is the generic name for Myrbetriq?
The generic name for Myrbetriq is mirabegron. There are 11 other brand versions of mirabegron.
What is the NDC code for Myrbetriq 50 mg/1?
The NDC (National Drug Code) for Myrbetriq 50 mg/1 is 0469-2602, listed by Astellas Pharma US, Inc..